{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:17:52Z","timestamp":1761175072308,"version":"build-2065373602"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pediatric differentiated thyroid cancer (DTC), particularly papillary thyroid carcinoma, is the most common endocrine malignancy in children and adolescents. Despite its aggressive presentation, including lymph nodes and distant metastases, pediatric DTC generally has an excellent prognosis. The 2015 American Thyroid Association (ATA) guidelines emphasize a risk-stratified approach, but dynamic risk stratification (DRS) has been less studied in this population. This study aimed to evaluate DRS in predicting persistent and recurrent disease in pediatric DTC over a mean follow-up of nearly 10 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on 88 pediatric patients with DTC who underwent surgery and radioactive iodine therapy (RAIT) between March 2009 and September 2017. Inclusion criteria were patients aged less than or equal to 18 years with postsurgical RAIT and at least 5 years of follow-up. DRS was applied based on clinical, biochemical, and imaging findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort had a mean age of 15 years, predominantly female (72.7%). At diagnosis, 70.5% had lymph node metastases, and 15.9% had distant metastases. DRS categorized patients into excellent response, biochemical incomplete response, and structural incomplete response. At the final follow-up, 86.4% of patients had complete or stable disease. High-risk patients required additional treatments, including repeat RAIT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DRS is a valuable tool for predicting persistent and recurrent disease in pediatric DTC, refining risk categories beyond ATA stratification. It provides a more personalized approach, potentially improving outcomes by identifying high-risk individuals for tailored treatment and follow-up. Further prospective studies are needed to standardize DRS in pediatric DTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mnm.0000000000001981","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T05:02:44Z","timestamp":1743483764000},"page":"613-619","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of I-131 therapy in pediatric and adolescent differentiated thyroid cancer: a long-term follow-up of a single-center Indian cohort"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3436-5262","authenticated-orcid":false,"given":"Ajit","family":"Nimmagadda","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakir Ali","family":"Abubacker","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prathyusha","family":"Bikkina","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virupakshappa","family":"C B","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi Pratyusha","family":"Paladugula","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"R1-20251022","doi-asserted-by":"crossref","first-page":"1270518","DOI":"10.3389\/fendo.2023.1270518","article-title":"Global incidence and prevalence of differentiated thyroid cancer in childhood: systematic review and meta-analysis.","volume":"14","author":"Moleti","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R2-20251022","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s13193-012-0130-x","article-title":"Pediatric thyroid cancers: an Indian perspective.","volume":"3","author":"Chaukar","year":"2012","journal-title":"Indian J Surg Oncol"},{"key":"R3-20251022","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.sla.0000205977.74806.0b","article-title":"Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus.","volume":"243","author":"Demidchik","year":"2006","journal-title":"Ann Surg"},{"key":"R4-20251022","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/CCO.0b013e3282f30220","article-title":"Differentiated thyroid cancer in children: diagnosis and management.","volume":"20","author":"Dinauer","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"R5-20251022","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.3390\/cancers13153732","article-title":"Differentiated thyroid cancer in children and adolescents: long term outcome and risk factors for persistent disease.","volume":"13","author":"Sapuppo","year":"2021","journal-title":"Cancers"},{"key":"R6-20251022","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/thy.2014.0460","article-title":"Management guidelines for children with thyroid nodules and differentiated thyroid cancer.","volume":"25","author":"FrancisGary","year":"2015","journal-title":"Thyroid"},{"key":"R7-20251022","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1210\/clinem\/dgac731","article-title":"Dynamic risk stratification for predicting long-term outcomes in pediatric differentiated thyroid cancers.","volume":"108","author":"Majeed","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20251022","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1089\/thy.2018.0075","article-title":"Dynamic risk stratification in the follow-up of children and adolescents with differentiated thyroid cancer.","volume":"28","author":"Zanella","year":"2018","journal-title":"Thyroid"},{"key":"R9-20251022","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12020-017-1381-7","article-title":"Validation of dynamic risk stratification in pediatric differentiated thyroid cancer.","volume":"58","author":"Sohn","year":"2017","journal-title":"Endocrine"},{"key":"R10-20251022","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4174\/astr.2018.95.4.222","article-title":"Usefulness of dynamic risk stratification in pediatric patients with differentiated thyroid carcinoma.","volume":"95","author":"Kim","year":"2018","journal-title":"Ann Surg Treat Res"},{"key":"R11-20251022","first-page":"793","article-title":"Initial and dynamic risk stratification of pediatric patients with differentiated thyroid cancer.","volume":"102","author":"Sung","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20251022","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1210\/jc.2015-3960","article-title":"Pediatric thyroid cancer: postoperative classifications and response to initial therapy as prognostic factors.","volume":"101","author":"Lazar","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20251022","first-page":"1531","article-title":"Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.","volume":"39","author":"Samuel","year":"1998","journal-title":"J Nucl Med"},{"key":"R14-20251022","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/105072504773297894","article-title":"Is chest X-ray or high-resolution computed tomography scan of the chest sufficient investigation to detect pulmonary metastasis in pediatric differentiated thyroid cancer?","volume":"14","author":"Bal","year":"2004","journal-title":"Thyroid"},{"key":"R15-20251022","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0002-9343(94)90342-5","article-title":"Long-term impact of initial and surgical therapy on papillary and follicular thyroid cancer.","volume":"97","author":"DeGroot","year":"1994","journal-title":"Am J Med"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000001981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:00:12Z","timestamp":1761120012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000001981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000001981","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"type":"print","value":"0143-3636"},{"type":"electronic","value":"1473-5628"}],"subject":[],"published":{"date-parts":[[2025,4,1]]}}}